ACN three-lens brief
Evidence-based stock research on ACN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Outperforming SPY by 38.7pp over 30 days.
ACN closed at $253.66 (-1.88%) as of 2026-11-12. Market cap: $149.85B. P/E (trailing) 18.7. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; outperforming SPY by 38.7pp over 30 days.. Last quarter: Revenue $18.68B, net income $1.99B, free cash flow $10.68B.
Why three lenses on ACN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ACN across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ACN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ACN brief"></iframe>